These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1114478)

  • 41. Detection of hemophilia A carriers by use of frozen plasma samples.
    Yang HC; Hardin J; Vaudreuil C
    Clin Chem; 1978 Sep; 24(9):1628-30. PubMed ID: 688629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved detection of haemophilia A carriers by factor VIII related antigen (radioimmunoassay) and bleeding symptoms.
    Wahlberg T; Blombäck M
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):339-46. PubMed ID: 6791292
    [No Abstract]   [Full Text] [Related]  

  • 43. [Processing data for predicting hemophilia transmission].
    Sikorová J; Zvárová J; Paluska E; Vorlová Z
    Vnitr Lek; 1984 Aug; 30(8):764-70. PubMed ID: 6438902
    [No Abstract]   [Full Text] [Related]  

  • 44. Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and B.
    Nugent DJ; Bray GL; Counts RB; Clements MJ; Thompson AR
    Br J Haematol; 1986 Nov; 64(3):493-502. PubMed ID: 3098273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postpartum haemorrhage in an unselected cohort of carriers of haemophilia.
    Zwagemaker A; Gouw SC; Valk C; Ganzevoort W; Coppens M; Peters M
    Haemophilia; 2018 Jul; 24(4):e256-e259. PubMed ID: 29808954
    [No Abstract]   [Full Text] [Related]  

  • 46. [Method of detecting the transmission of hemophilia: report of the WHO].
    Bull World Health Organ; 1979; 57(4):579-609. PubMed ID: 316737
    [No Abstract]   [Full Text] [Related]  

  • 47. Carrier detection and prenatal diagnosis in haemophilia A and B.
    Chistolini A; Papacchini M; Mazzucconi MG; La Verde G; Arcieri R; Ferrari A; Paesano R; Pachi A; Mariani G
    Haematologica; 1990; 75(5):424-8. PubMed ID: 1982946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of the value of factor VIII procoagulant and antigen ratio in the diagnosis of carriers of haemophilia.
    D'Souza S; Ekert H; Ananthakrishnan R; Muntz RH
    Aust N Z J Med; 1976 Jun; 6(3):218-22. PubMed ID: 1067820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of carriers and babies with haemophilia.
    Street AM; Ljung R; Lavery SA
    Haemophilia; 2008 Jul; 14 Suppl 3():181-7. PubMed ID: 18510540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison between a serum fraction and FEIBA fraction in haemophilia.
    Hutton RA; Dormandy K; Nour-Eldin F
    New Istanbul Contrib Clin Sci; 1980; 13(1):9-22. PubMed ID: 6774316
    [No Abstract]   [Full Text] [Related]  

  • 52. Factor viii-related antigen in the detection of the haemophilia carrier state.
    Gomperts ED; Whitbread P; Feesey M
    S Afr Med J; 1975 Jun; 49(25):1005-7. PubMed ID: 1154143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Inhibitors and "bypass" therapy in hemophilia].
    Fukutake K; Fukutake K
    Nihon Rinsho; 1981; 39(12):3688-99. PubMed ID: 6803034
    [No Abstract]   [Full Text] [Related]  

  • 54. [Degree of severity of hemophilia. Relationship between blood coagulation tests and clinical findings].
    Weissbach G; Bührdel P
    Dtsch Gesundheitsw; 1971 Aug; 26(33):1570-5. PubMed ID: 5113164
    [No Abstract]   [Full Text] [Related]  

  • 55. Two forms of haemophilia.
    Nour-Eldin F
    Lancet; 1968 Sep; 2(7567):572. PubMed ID: 4175422
    [No Abstract]   [Full Text] [Related]  

  • 56. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 57. Inheritable molecular variants of moderate and mild hemophilia A.
    Ljung R; Holmberg L; Nilsson IM
    Acta Med Scand; 1981; 209(1-2):11-6. PubMed ID: 6782836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A.
    Labarque V; Perinparajah V; Bouskill V; Stain AM; Wakefield C; Manuel C; Blanchette VS; James PD; Lillicrap D; Carcao MD
    Am J Hematol; 2017 Jun; 92(6):E94-E96. PubMed ID: 28249352
    [No Abstract]   [Full Text] [Related]  

  • 59. Plasma fractionation methods and T-cell subsets in haemophilia.
    Lee CA; Janossy G; Ashley J; Kernoff PB
    Lancet; 1983 Jul; 2(8342):158-9. PubMed ID: 6134999
    [No Abstract]   [Full Text] [Related]  

  • 60. Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data.
    Ivaskevicius V; Jurgutis R; Rost S; Müller A; Schmitt C; Wulff K; Herrmann FH; Müller CR; Schwaab R; Oldenburg J
    Br J Haematol; 2001 Mar; 112(4):1062-70. PubMed ID: 11298607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.